Women's Health Group, Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, North Carolina, USA.
Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.
Environ Health Perspect. 2023 Jan;131(1):17006. doi: 10.1289/EHP11089. Epub 2023 Jan 25.
Uterine fibroids are highly prevalent, benign tumors. They are the leading indication for hysterectomy, and Black women are disproportionally burdened. Soy-based infant formula contains phytoestrogens, and exposure during sensitive developmental windows may adversely affect the developing uterus; early phytoestrogen treatment in rodent studies led to detrimental uterine effects, including increased fibroid risk in Eker rats. Limited epidemiological studies also have suggested increased fibroid development with soy formula infant feeding.
The goal of this study was to examine the association between soy formula feeding in infancy and fibroid development in adulthood.
We evaluated this association among 1,610 Black/African-American women age 23-35 y in the Study of Environment, Lifestyle & Fibroids (SELF). Soy formula feeding data was gathered directly from the participants' mothers (89%). A standardized ultrasound examination was conducted during 4 clinic visits over 5 y to detect fibroids in diameter. We used Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between soy formula feeding and incident fibroids adjusted for early-life and adult factors. Fibroid growth was calculated as change in log-volume for fibroids matched at successive visits.
Of 1,121 fibroid-free participants at baseline, 150 (13%) were ever fed soy formula as infants, and 269 (24%) developed incident fibroids. We did not observe an association between ever being fed soy formula and incident fibroid risk (; 95% CI: 0.75, 1.54). However, participants fed soy formula within 2 months of birth and for () had an elevated risk of fibroid incidence in comparison with those never fed soy formula (; 95% CI: 0.92, 2.65). Fibroid growth rates did not differ.
Adding support to limited human data, this prospective fibroid study found that soy-based formula feeding during infancy was associated with a suggestive increase in risk of ultrasound-identified incident fibroids in adulthood. https://doi.org/10.1289/EHP11089.
子宫肌瘤是一种高度普遍存在的良性肿瘤。它是子宫切除术的主要指征,而黑人女性的负担不成比例。大豆配方奶粉含有植物雌激素,在敏感的发育窗口期间暴露可能会对发育中的子宫产生不利影响;在啮齿动物研究中,早期植物雌激素治疗导致子宫有害影响,包括 Eker 大鼠的肌瘤风险增加。有限的流行病学研究还表明,大豆配方奶粉喂养与肌瘤发育增加有关。
本研究旨在研究婴儿期大豆配方喂养与成年后子宫肌瘤发展之间的关系。
我们在环境、生活方式和纤维瘤研究(SELF)中评估了 1610 名 23-35 岁的黑人/非裔美国女性之间的这种关联。大豆配方喂养数据直接从参与者的母亲(89%)处收集。在 5 年内进行了 4 次临床访视,通过超声检查直径检测子宫肌瘤。我们使用 Cox 比例风险回归估计大豆配方喂养与新发性肌瘤之间的关联的风险比(HR)和 95%置信区间(CI),调整了生命早期和成年期的因素。根据连续就诊时的肌瘤匹配,计算肌瘤的生长情况作为肌瘤对数体积的变化。
在基线时,1121 名无肌瘤的参与者中,有 150 名(13%)在婴儿期曾经喂养过大豆配方奶粉,有 269 名(24%)发生了新发性肌瘤。我们没有观察到曾经喂养大豆配方奶粉与新发性肌瘤风险之间存在关联(;95%CI:0.75,1.54)。然而,与从未喂养过大豆配方奶粉的参与者相比,出生后 2 个月内和(或)喂养()大豆配方奶粉的参与者发生子宫肌瘤的风险增加(;95%CI:0.92,2.65)。肌瘤生长速度没有差异。
这项前瞻性纤维瘤研究增加了有限的人类数据支持,发现婴儿期喂养大豆配方奶粉与成年后超声识别的新发性子宫肌瘤风险增加有关。https://doi.org/10.1289/EHP11089.